123191-00-4

Basic information

• Product Name: 1-(TRIISOPROPYLSILYL)INDOLE
• Synonyms: TRIISOPROPYLSILYLINDOLE;1-(TRIISOPROPYLSILYL)INDOLE 97+%;1-(TRIISOPROPYLSILYL)INDOLE
• CAS NO: 123191-00-4
• Molecular Formula: C₁₇H₂₇NSi
• Molecular Weight: 273.49
• Product Categories: Indoles;Si (Classes of Silicon Compounds);Simple Indoles;Si-N Compounds;Trimethylsilylazide, etc.
• Mol File: 123191-00-4.mol

Chemical Properties

• Boiling Point: 298.4°Cat760mmHg
• Flash Point: 134.3°C
• Appearance: /
• Density: 0.99
• Vapor Pressure: 0.001mmHg at 25°C
• Refractive Index: 1.509
• CAS DataBase Reference: 1-(TRIISOPROPYLSILYL)INDOLE(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(TRIISOPROPYLSILYL)INDOLE(123191-00-4)
• EPA Substance Registry System: 1-(TRIISOPROPYLSILYL)INDOLE(123191-00-4)

Safety Data

• Hazardous Substances Data: 123191-00-4(Hazardous Substances Data)

Usage

Uses

Used in Organic Synthesis:
1-(TRIISOPROPYLSILYL)INDOLE is used as a protecting group for the indole ring during organic synthesis, allowing for selective reactions of other functional groups. This selective protection is crucial for the synthesis of complex organic molecules, where the indole ring's integrity must be maintained.
Used in Medicinal Chemistry:
1-(TRIISOPROPYLSILYL)INDOLE is studied for its potential biological activities, such as its ability to inhibit certain enzymes and receptors in the central nervous system. This makes it a candidate for the development of new drugs targeting neurological disorders or conditions.

InChI:InChI=1/C17H27NSi/c1-13(2)19(14(3)4,15(5)6)18-12-11-16-9-7-8-10-17(16)18/h7-15H,1-6H3

Upstream product

• 120-72-9 indole 
• 13154-24-0 triisopropylsilyl chloride 
• 108030-46-2 (E,E)-1-(N,N-dimethylamino)-4-nitro-1,3-butadiene 
• 148249-36-9 3-bromo-1-(1,1,1-triisopropylsilyl)-1H-indole 
• 123-75-1 pyrrolidine 
• 128564-66-9 5-bromo-1-triisopropylsilyl-1H-indole 
• 5419-55-6 Triisopropyl borate 
• 7732-18-5 water 

Downstream Products

• 82645-10-1 4-phenylthioindole 
• 1004517-30-9 3-[1-(2-phenylphenyl)-2-propynyl]-1-triisopropylsilylindole 
• 1004517-31-0 3-[1-(3,5-diphenylphenyl)-2-propynyl]-1-triisopropylsilylindole 
• 1004517-27-4 3-[1-(4-methylphenyl)-2-propynyl]-1-triisopropylsilylindole 
• 1004517-28-5 3-[1-(4-chlorophenyl)-2-propynyl]-1-triisopropylsilylindole 
• 1004517-29-6 3-[1-(4-phenylphenyl)-2-propynyl]-1-triisopropylsilylindole 
• 1004517-21-8 3-(1-phenyl-2-propynyl)-1-triisopropylsilylindole 
• 1116153-99-1 C₃₈H₄₁NSi 
• 1116153-95-7 C₂₇H₃₅NSi 
• 1116153-96-8 C₂₆H₃₂ClNSi 
• 1116153-97-9 C₃₂H₃₇NSi 
• 1116153-94-6 C₂₆H₃₃NSi 
• 1144105-44-1 C₃₅H₄₆N₂O₂Si 

Relevant articles and documents

A Highly Enantioselective Asymmetric Hydrogenation Route to β-(2R,3S)-Methyltryptophan

Asymmetric hydrogenation of a protected (Z)-dehydro-β-methyltryptophan derivative 2 with (R,R)-Me-DuPHOS-Rh catalysis was achieved in 97percent ee.Deprotection then afforded (2R,3S)-β-methyltryptophan 1.

NOVEL PYRIDIN-2(1H)ONE DERIVATIVES, THEIR PREPARATION AND THEIR USE FOR THE TREATMENT OF PAIN

The present invention concerns novel pyridin-2(1H)one derivatives, their process of preparation and their use in therapeutics, in particular as agents for treating and/or preventing pain.

Pyridin-2(1H)one derivatives: A possible new class of therapeutics for mechanical allodynia

Mechanical Allodynia (MA), a frequent chronic pain symptom caused by innocuous stimuli, constitutes an unmet medical need, as treatments using analgesics available today are not always effective and can be associated with important side-effects. A series of 3,5-disubstituted pyridin-2(1H)-ones was designed, synthesized and evaluated in vivo toward a rat model of inflammatory MA. We found that the series rapidly and strongly prevented the development of MA. 3-(2-Bromophenyl)-5-(phenylamino)pyridin-2(1H)-one 69, the most active compound of the series, was also able to quickly reverse neuropathic MA in rats. Next, when 69 was evaluated toward a panel of 50 protein kinases (PK) in order to identify its potential biological target(s), we found that 69 is a p38α MAPK inhibitor, a PK known to contribute to pain hypersensitivity in animal models. 3,5-Disubstituted pyridin-2(1H)-ones thus could represent a novel class of analgesic for the treatment of MA.

Boronic Acid Accelerated Three-Component Reaction for the Synthesis of α-Sulfanyl-Substituted Indole-3-acetic Acids

Boronic acid was used to accelerate a three-component reaction of indoles, thiols, and glyoxylic acids for the synthesis of α-sulfanyl-substituted indole-3-acetic acids. Boronic acid catalysis to activate the α-hydroxy group in α-hydroxycarboxylic acid in

Me2AlCl-mediated carboxylation, ethoxycarbonylation, and carbamoylation of indoles

Various 1-methyl-, 1-triisopropylsilyl-, and 1-benzylindoles are carboxylated under CO2 pressure (3.0 MPa) with the aid of 1.0 molar equiv of Me2AlCl to give 1-substituted indole-3-carboxylic acids in good to excellent yields. Mechanistic studies suggest that the intermediate, an indol-3-ylaluminum ate complex, was reversibly formed by electrophilic addition of Me2AlCl to the substrate followed by deprotonation of the resulting adduct. This method is successfully extended to alkoxycarbonylation with ethyl chloroformate and carbamoylation with naphthalen-1-yl isocyanate, which afford ethyl indole-3-carboxylates and N-naphthalen-1-ylindole-3-carboxamides, respectively.

4-Substituted Pyrrolo[2,3-d]pyrimidine Compound and Use Thereof

The invention relates to a 4-substituted pyrrolo[2,3-d]pyrimidine compound and the use thereof in preparing medications for treating JAK-targeted diseases such as rheumatoid, immune system diseases, and tumor. The 4-substituted pyrrolo[2,3-d]pyrimidine compound of the invention is as shown in chemical formula I. The activity experimental results of the invention show that the new compound has obvious effect and activity in inhibition of Janus kinases, JAK-STAT, cell proliferation of human lymphocytoma, and rheumatoid arthritis.

Au-Catalyzed Cross-Coupling of Arenes via Double C-H Activation

The first methodology for Au(I/III)-catalyzed oxidative cross-coupling of arenes via double C-H activation has been developed. The reaction is fully selective for the cross-coupling between electron-rich hetero-/carbocyclic arenes and electron-poor arenes bearing relatively acidic C-H bonds. The inherently high cross-selectivity of the system obviates the need for directing groups or a large excess of one of the coupling partners.

NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE

Provided are a nitrogen-containing aromatic heterocyclic compound useful as an organic semiconductor material and an organic electronic device using this compound. The nitrogen-containing aromatic heterocyclic compound has a fused indole skeleton represented by the following formula (1), the organic semiconductor material contains the said compound, and the organic electronic device uses the said organic semiconductor material. In general formula (1), X is N-A', O, S, or Se; A is an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aromatic hydrocarbon group, or an aromatic heterocyclic group exclusive of a fused heterocycle consisting of 4 rings or more; and R is a hydrogen atom, an alkyl group, a cycloalkyl group, an alkenyl group, an alkynyl group, an aromatic hydrocarbon group, or an aromatic heterocyclic group exclusive of a fused heterocycle consisting of 4 rings or more.

NITROGENATED AROMATIC COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL, AND ORGANIC ELECTRONIC DEVICE

Provided are a novel nitrogen-containing aromatic heterocyclic compound and an organic electronic device using the compound. This nitrogen-containing aromatic compound is represented by the general formula (1). Further, the present invention relates to or

Asymmetric synthesis of indole homo-Michael adducts via dynamic kinetic Friedel-Crafts alkylation with cyclopropanes

An enantioconvergent Friedel-Crafts alkylation of indoles with donor-acceptor cyclopropanes is described. The reaction is catalyzed by pybox?MgI2 and proceeds via a type I dynamic kinetic asymmetric transformation (DyKAT).